SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-028044
Filing Date
2024-03-07
Accepted
2024-03-07 16:31:54
Documents
13
Period of Report
2024-03-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cyt-20240307.htm   iXBRL 8-K 46603
2 EX-99.1 cyt-ex99_1.htm EX-99.1 6515
  Complete submission text file 0000950170-24-028044.txt   170811

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cyt-20240307.xsd EX-101.SCH 28051
14 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20240307_htm.xml XML 4696
Mailing Address P.O. BOX 80084 STONEHAM MA 02180
Business Address P.O. BOX 80084 STONEHAM MA 02180 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40499 | Film No.: 24730637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)